GO:1904823 purine nucleobase transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904823 describes the biological process in which a purine nucleobase (e.g., adenine, guanine, hypoxanthine) is transported across a membrane.
• Nucleobase transport is mediated by specific membrane proteins, including members of the equilibrative nucleoside transporter (ENT) family and dedicated nucleobase transporters [1,6].
• The process is essential for nucleotide salvage, cellular homeostasis, and drug uptake, with implications for cancer and infectious diseases [1,7].
• Key genes include SLC29A1 (hENT1), SLC29A2, and fungal/plant transporters such as those in Aspergillus nidulans and Phanerochaete chrysosporium [3,4,5].
• Recent structural and mechanistic studies have revealed proton-coupled transport mechanisms for nucleobases [2,8].
• CRISPR-based models (knockout, knock-in, point mutation) enable precise dissection of transporter function and their roles in disease.
Description
Purine nucleobase transmembrane transport (GO:1904823) is the process by which purine nucleobases such as adenine, guanine, and hypoxanthine are moved across biological membranes. This process is fundamental for nucleotide salvage pathways, allowing cells to recycle nucleobases rather than synthesizing them de novo, and it also governs the cellular uptake of certain drugs [1,7]. Understanding this transport is critical for researchers studying metabolism, drug resistance, and membrane protein function [1,6]. The transport is mediated by specialized membrane proteins, including members of the equilibrative nucleoside transporter (ENT) family, which can also transport nucleobases [3,6]. Recent studies have elucidated the molecular mechanisms, such as proton-coupled transport in fungal and plant systems [2,8]. This article provides a comprehensive overview of GO:1904823, covering its definition, key genes, regulatory aspects, disease relevance, and research methodologies, with a focus on CRISPR-based approaches for functional studies.
purine nucleobase transmembrane transport At A Glance
| GO ID | GO:1904823 |
|---|---|
| GO term | purine nucleobase transmembrane transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Transport of purine nucleobases across membranes |
| Definition | The process in which a purine nucleobase is transported across a membrane. |
| Related transporters | Equilibrative nucleoside transporters (ENTs), nucleobase-specific transporters |
| Substrates | Adenine, guanine, hypoxanthine, xanthine |
| Cellular location | Plasma membrane, intracellular membranes |
What Is GO:1904823?
GO:1904823, purine nucleobase transmembrane transport, is defined as the process in which a purine nucleobase is transported across a membrane. This encompasses the movement of purine nucleobases (e.g., adenine, guanine, hypoxanthine, xanthine) from one side of a lipid bilayer to the other, typically mediated by integral membrane transport proteins [1,6]. The process is distinct from nucleoside transport, although some transporters can handle both substrates.
Why Is purine nucleobase transmembrane transport Important in Cell Biology?
Purine nucleobase transmembrane transport is vital for cellular nucleotide homeostasis, as it enables the salvage of purine bases for nucleotide synthesis and regulates the intracellular concentration of these metabolites [1,7]. Defects in transport can lead to imbalances in nucleotide pools, affecting DNA replication, RNA synthesis, and energy metabolism. Furthermore, these transporters are involved in the uptake of antimetabolite drugs used in cancer and antiviral therapy, making them key determinants of drug sensitivity and resistance [3,7]. Understanding this process is therefore essential for both basic cell biology and translational research.
• Maintains intracellular purine nucleobase pools for nucleotide salvage.
• Influences drug uptake and resistance, particularly for nucleobase analogs used in cancer and viral infections [3,7].
• Plays a role in purine metabolism disorders such as Lesch-Nyhan syndrome and gout.
• Mediates purine acquisition in pathogenic organisms, making transporters potential drug targets [1,5].
• Regulates cellular responses to nutrient availability and stress.
• Involved in plant cytokinin transport, affecting growth and development.
• Contributes to the pharmacokinetics of nucleobase-derived drugs.
• Provides a model for studying membrane protein structure and mechanism [2,6].
What Happens During purine nucleobase transmembrane transport?
Substrate Recognition and Binding
In simple terms: The transporter protein recognizes and binds to a specific purine nucleobase on one side of the membrane.
Transporters involved in purine nucleobase transport exhibit substrate specificity, recognizing purine bases such as adenine, guanine, and hypoxanthine. For example, the human equilibrative nucleoside transporter 1 (hENT1) can bind nucleobases, although its primary substrates are nucleosides. Structural studies of the Arabidopsis cytokinin transporter AZG1 have revealed how purine-derived substrates are recognized. In fungal systems, specific purine transporters have been characterized, showing high affinity for purine bases.
Conformational Changes and Translocation
In simple terms: The transporter changes shape to move the nucleobase across the membrane.
Upon substrate binding, transporters undergo conformational changes that allow the nucleobase to be translocated across the lipid bilayer. Recent mechanistic studies on H+-coupled nucleobase transport have provided insights into the coupling of proton movement with substrate translocation. The alternating access model is commonly used to describe this process, where the transporter alternates between outward-facing and inward-facing conformations.
Energy Coupling and Driving Forces
In simple terms: Some transporters use energy, such as proton gradients, to drive transport.
Purine nucleobase transport can be driven by concentration gradients (facilitated diffusion) or coupled to ion gradients (secondary active transport) [1,2]. For instance, H+-coupled nucleobase transporters utilize the proton motive force to accumulate substrates against their concentration gradient. In contrast, equilibrative transporters such as hENT1 mediate passive transport down the concentration gradient [3,6].
Release and Cellular Utilization
In simple terms: Once inside, the nucleobase is released and used by the cell.
After translocation, the nucleobase is released into the cytoplasm, where it can enter salvage pathways for nucleotide synthesis or be further metabolized [1,7]. HPLC-based studies have revealed that nucleobase homeostasis is tightly linked to nucleoside metabolism and transport. The transported nucleobases can also be incorporated into nucleic acids or act as signaling molecules.
Key Genes Involved in GO:1904823 purine nucleobase transmembrane transport
The following genes encode proteins that mediate or regulate purine nucleobase transmembrane transport, based on experimental evidence from various organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC29A1 (hENT1) | Equilibrative nucleoside transporter 1; transports nucleosides and nucleobases | Drug uptake, cancer resistance [3,6] |
| SLC29A2 (hENT2) | Equilibrative nucleoside transporter 2; broad substrate specificity | Nucleoside and nucleobase transport |
| SLC29A3 | Equilibrative nucleoside transporter 3 | Histiocytosis, nucleoside transport |
| SLC29A4 | Equilibrative nucleoside transporter 4 | Nucleoside transport |
| Azg1 (Arabidopsis) | Cytokinin transporter; transports purine-derived cytokinins | Plant growth and development |
| PhcG (Phanerochaete chrysosporium) | Purine transporter | Fungal purine uptake |
| Aspergillus nidulans purine transporters | Membrane proteins for purine uptake | Fungal metabolism |
| UapA (Aspergillus nidulans) | Uric acid-xanthine permease | Purine catabolism |
| UapC (Aspergillus nidulans) | Uric acid-xanthine permease | Purine catabolism |
| Azg2 (Arabidopsis) | Cytokinin transporter | Plant hormone transport |
| ENT1 (human) | Equilibrative nucleoside transporter | Drug transport |
| ENT2 (human) | Equilibrative nucleoside transporter | Nucleoside transport |
| CNT1 (human) | Concentrative nucleoside transporter | Nucleoside transport |
| CNT2 (human) | Concentrative nucleoside transporter | Nucleoside transport |
| CNT3 (human) | Concentrative nucleoside transporter | Nucleoside transport |
| FNT (fungal) | Fungal nucleobase transporter | Purine salvage |
| PbuX (Bacillus subtilis) | Xanthine permease | Purine transport |
How Is purine nucleobase transmembrane transport Regulated?
The regulation of purine nucleobase transmembrane transport occurs at multiple levels. Transcriptional regulation of transporter genes can be influenced by nutrient availability and stress. For example, in Aspergillus nidulans, the expression of purine transporters is regulated by the nitrogen metabolite repression pathway. Post-translational modifications, such as phosphorylation, may also modulate transporter activity. Additionally, the activity of equilibrative nucleoside transporters can be regulated by protein kinases, although specific mechanisms for nucleobase transport are less defined. In plants, cytokinin transport via AZG1 is regulated in response to developmental and environmental cues.
purine nucleobase transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC29A1 | Cancer drug resistance | Knockout in cancer cell lines |
| SLC29A2 | Nucleoside transport deficiency | Knockout in HEK293 cells |
| PhcG | Fungal purine uptake | Point mutation in P. chrysosporium |
| Azg1 | Plant development | Knockout in Arabidopsis |
| UapA | Fungal purine catabolism | Knockout in A. nidulans |
Cancer and Drug Resistance
Purine nucleobase transporters, particularly hENT1, are critical for the cellular uptake of nucleoside analog drugs used in cancer chemotherapy, such as gemcitabine and cytarabine [3,7]. Reduced expression or function of these transporters can lead to drug resistance, making them important biomarkers and therapeutic targets. Additionally, altered purine transport can affect nucleotide pools, influencing cancer cell proliferation.
Purine Metabolism Disorders
Defects in purine nucleobase transport can contribute to disorders of purine metabolism, such as Lesch-Nyhan syndrome and gout, by disrupting the salvage of hypoxanthine and guanine. Although direct mutations in transporters are rare, impaired transport can exacerbate metabolic imbalances.
Infectious Diseases
Purine transporters in pathogens, such as fungi and protozoa, are essential for scavenging purines from the host, making them potential drug targets [1,5]. For example, the purine transporter of Phanerochaete chrysosporium has been studied for its role in fungal physiology. Inhibiting these transporters could starve pathogens of essential nutrients.
From purine nucleobase transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC29A1 mediate purine nucleobase transport? | Knockout in HeLa or HEK293 cells |
| What is the substrate specificity of a novel transporter? | Overexpression in Xenopus oocytes |
| How does a point mutation affect transport activity? | Point mutation knock-in in cell lines |
| Where is the transporter localized? | Tagged knock-in with GFP |
| What is the role of a transporter in drug resistance? | Knockout in cancer cell lines followed by drug sensitivity assays |
| Can a transporter be targeted for antifungal therapy? | Knockout in fungal strains |
How to Study the purine nucleobase transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and substrate specificity | Functional characterization of transporters |
| HPLC | Intracellular nucleobase/nucleoside concentrations | Metabolic profiling |
| Cryo-EM | 3D structure of transporter | Mechanistic studies |
| CRISPR knockout | Loss-of-function phenotype | Gene function validation |
| Site-directed mutagenesis | Effect of point mutations on activity | Structure-function analysis |
| Overexpression | Gain-of-function and kinetics | Heterologous expression |
| RNA-seq | Transcriptional regulation of transporters | Expression profiling |
| Proteomics | Protein abundance and interactions | Transporter regulation |
Transport Assays
Radiolabeled or fluorescent nucleobase uptake assays are used to measure transport activity in cells or membrane vesicles [1,3]. HPLC-based methods can quantify intracellular nucleobase and nucleoside levels to assess transport and metabolism.
Structural Biology
X-ray crystallography and cryo-electron microscopy provide high-resolution structures of transporters, revealing substrate binding sites and conformational changes [2,8]. These methods are essential for understanding the molecular mechanism of transport.
Genetic Manipulation
CRISPR-Cas9 knockout, knock-in, and point mutation models allow functional dissection of transporter genes in various organisms. Overexpression in heterologous systems, such as Xenopus oocytes or HEK293 cells, is used for detailed kinetic analysis.
Bioinformatics and Genomics
Genome-wide screens and comparative genomics identify novel transporter genes and regulatory elements. Bioinformatics tools predict membrane topology and substrate specificity.
How CRISPR Can Be Used to Study GO:1904823 purine nucleobase transmembrane transport
Knockout
CRISPR-Cas9 knockout of transporter genes (e.g., SLC29A1) in cell lines abolishes transport activity, allowing researchers to study the physiological consequences, such as altered drug sensitivity or nucleotide pool imbalances [3,5]. Knockout models are also used in fungi to assess the role of specific transporters in purine uptake.
Point Mutation
Introducing point mutations in transporter genes via CRISPR can mimic naturally occurring variants or disrupt key residues, enabling structure-function studies. For example, mutational analysis of the Phanerochaete chrysosporium purine transporter identified residues critical for substrate recognition.
Knock-in
Knock-in of tagged transporters (e.g., GFP or FLAG) allows visualization and biochemical purification of the transporter to study localization, trafficking, and interactions. This approach is valuable for understanding how transporters are regulated in vivo.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase transporter levels, facilitating kinetic studies and structural analysis. Overexpression in heterologous systems is often used to characterize transport mechanisms.
How EDITGENE Supports purine nucleobase transmembrane transport Research
Researchers studying purine nucleobase transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for purine nucleobase transmembrane transport research.
Frequently Asked Questions About purine nucleobase transmembrane transport
What is GO:1904823?
GO:1904823 is the Gene Ontology term for purine nucleobase transmembrane transport, the process of moving purine nucleobases across a membrane.
What genes are involved in purine nucleobase transmembrane transport?
Key genes include SLC29A1 (hENT1), SLC29A2, and fungal transporters like PhcG, as well as plant AZG1 [3,5,8].
How is purine nucleobase transport regulated?
It is regulated transcriptionally by nutrient availability and post-translationally by phosphorylation, though specific mechanisms vary by organism [1,4].
What diseases are associated with defects in purine nucleobase transport?
Defects can contribute to cancer drug resistance, purine metabolism disorders, and infectious diseases [1,3].
What methods are used to study purine nucleobase transport?
Common methods include radiolabeled uptake assays, HPLC, cryo-EM, and CRISPR-based genetic manipulation [1,2,7].
Can CRISPR be used to study purine nucleobase transporters?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools for dissecting transporter function.
What is the role of hENT1 in purine nucleobase transport?
hENT1 (SLC29A1) is an equilibrative transporter that can transport nucleobases and is important for drug uptake.
Are there specific inhibitors of purine nucleobase transporters?
Some inhibitors exist, such as nitrobenzylthioinosine for ENT1, but specific nucleobase transport inhibitors are less characterized.
How does purine nucleobase transport affect nucleotide salvage?
It provides purine bases for salvage pathways, allowing cells to recycle nucleotides and maintain pools.
What model organisms are used to study purine nucleobase transport?
Aspergillus nidulans, Phanerochaete chrysosporium, Arabidopsis thaliana, and human cell lines are commonly used [4,5,8].
Conclusion
Purine nucleobase transmembrane transport (GO:1904823) is a fundamental biological process that impacts nucleotide metabolism, drug response, and microbial pathogenesis. Advances in structural biology and CRISPR-based genetics have deepened our understanding of the transporters involved and their mechanisms [2,5,8]. Continued research in this area holds promise for developing new therapeutic strategies targeting these transporters in cancer and infectious diseases [1,3]. EDITGENE's suite of CRISPR services can empower researchers to explore this process with precision and efficiency.
References
- 1. de Koning H et al.. 2000. Nucleobase transporters (review).. Mol Membr Biol 17(2):75-94 PMID: 10989458
- 2. Weng J et al.. 2023. Insight into the mechanism of H(+)-coupled nucleobase transport.. Proc Natl Acad Sci U S A 120(33):e2302799120 PMID: 37549264
- 3. Yao SY et al.. 2011. Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).. J Biol Chem 286(37):32552-62 PMID: 21795683
- 4. Dessen P et al.. 2000. The PAUSE software for analysis of translational control over protein targeting: application to E. nidulans membrane proteins.. Gene 244(1-2):89-96 PMID: 10689191
- 5. Barraco-Vega M et al.. 2024. Mutational analysis of Phanerochaete chrysosporium´s purine transporter.. PLoS One 19(10):e0313174 PMID: 39480815
- 6. Baldwin SA et al.. 2004. The equilibrative nucleoside transporter family, SLC29.. Pflugers Arch 447(5):735-43 PMID: 12838422
- 7. Altaweraqi RA et al.. 2020. HPLC reveals novel features of nucleoside and nucleobase homeostasis, nucleoside metabolism and nucleoside transport.. Biochim Biophys Acta Biomembr 1862(7):183247 PMID: 32126230
- 8. Xu L et al.. 2024. Structures and mechanisms of the Arabidopsis cytokinin transporter AZG1.. Nat Plants 10(1):180-191 PMID: 38172575
